Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Late Onset Autoimmune Diabetes in Adults | Research

Clinical characteristics of patients with early-onset diabetes mellitus: a single-center retrospective study

Authors: Wenjing Dong, Saichun Zhang, Shiju Yan, Zhizhuang Zhao, Zengqiang Zhang, Weijun Gu

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

The prevalence of diabetes mellitus (DM) is dramatically increasing around the world, and patients are getting younger with changes in living standards and lifestyle. This study summarized and analyzed the clinical characteristics of different types of newly diagnosed diabetes mellitus patients with an onset age between 18 and 40 years to provide clinical evidence for the early diagnosis and treatment of diabetes, reduce short-term and long-term complications and offer scientific and personalized management strategies.

Methods

A total of 655 patients newly diagnosed with early-onset diabetes mellitus in the Department of Endocrinology, the First Medical Center of PLA General Hospital from January 2012 to December 2022 were retrospectively enrolled in this study, with an onset age of 18–40 years. Their clinical data were collected and investigated. All patients were divided into two groups according to whether they presented with diabetic microangiopathy. Similarly, patients with early-onset type-2 diabetes were grouped in accordance with whether they had ketosis at the time of diagnosis. Binary logistic regression analysis was performed to analyze risk factors, and receiver-operating characteristic (ROC) analysis was used to explore the predictive value of significant risk factors.

Results

The findings were as follows: (1) Of 655 enrolled patients, 477 (72.8%) were male and 178 (27.1%) were female, with a mean age of onset of was 29.73 years ± 0.24 SD. (2) The prevalence of early-onset diabetes was gradually increasing. Type-2 diabetes was the most common type of early-onset diabetes (491, 75.0%). The ages of onset of early-onset type-1 diabetes, type-2 diabetes and LADA were mainly 18–24 years, 25–40 years and 33–40 years, respectively. (3) Initial clinical manifestations of early-onset diabetes were classic diabetes symptoms (361, 55.1%), followed by elevated blood glucose detected through medical examination (207, 31.6%). (4) Binary logistic regression analysis suggested that high serum uric acid (UA), a high urinary albumin-to-creatinine ratio (UACR) and diabetic peripheral neuropathy (DPN) were risk factors for microangiopathy in early-onset diabetes patients (P < 0.05). The area under the curve (AUC) on ROC analysis of the combination of UA, UACR and DPN was 0.848, 95% CI was 0.818 ~ 0.875, sensitivity was 73.8% and specificity was 85.9%, which had higher predictive value than those of UA, UACR and DPN separately. (5) Weight loss, high glycosylated hemoglobin (HbA1c) and young onset age were risk factors for ketosis in patients with early-onset type-2 diabetes (P < 0.05).

Conclusion

(1) Men were more likely to have early-onset diabetes than women. (2) Early-onset diabetes patients with high serum uric acid levels, high UACRs and peripheral neuropathy were prone to microangiopathy. Comprehensive evaluation of these risk factors could have higher predictive value in the prediction, diagnosis and treatment of microvascular lesions. (3) Patients with weight loss at onset, high HbA1c and young onset age were more likely to develop ketosis. Attention should be given to the metabolic disorders of these patients.
Literature
1.
go back to reference Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80.CrossRefPubMed Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80.CrossRefPubMed
2.
go back to reference Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281(1):64–91.CrossRefPubMedPubMedCentral Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281(1):64–91.CrossRefPubMedPubMedCentral
3.
go back to reference Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, Imperatore G, Linder B, Marcovina S, Pettitt DJ, et al. Incidence Trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376(15):1419–29.CrossRefPubMedPubMedCentral Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, Imperatore G, Linder B, Marcovina S, Pettitt DJ, et al. Incidence Trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376(15):1419–29.CrossRefPubMedPubMedCentral
4.
go back to reference Liu JJ, Liu S, Gurung RL, Ang K, Tang WE, Sum CF, Tavintharan S, Lim SC. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study. Nephrol Dial Transplant. 2020;35(1):115–21.PubMed Liu JJ, Liu S, Gurung RL, Ang K, Tang WE, Sum CF, Tavintharan S, Lim SC. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: a prospective cohort study. Nephrol Dial Transplant. 2020;35(1):115–21.PubMed
5.
go back to reference Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al. Prevalence and ethnic pattern of diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–23.CrossRefPubMedPubMedCentral Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al. Prevalence and ethnic pattern of diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–23.CrossRefPubMedPubMedCentral
6.
go back to reference Liu JJ, Liu S, Wang J, Lee J, Tang JI, Gurung RL, Ang K, Shao YM, Tavintharan S, Tang WE, et al. Risk of Incident Heart failure in individuals with early-onset type 2 diabetes. J Clin Endocrinol Metab. 2022;107(1):e178–87.CrossRefPubMed Liu JJ, Liu S, Wang J, Lee J, Tang JI, Gurung RL, Ang K, Shao YM, Tavintharan S, Tang WE, et al. Risk of Incident Heart failure in individuals with early-onset type 2 diabetes. J Clin Endocrinol Metab. 2022;107(1):e178–87.CrossRefPubMed
7.
go back to reference Zou X, Zhou X, Ji L, Yang W, Lu J, Weng J, Jia W, Shan Z, Liu J, Tian H, et al. The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study. Sci Rep. 2017;7:46534.CrossRefPubMedPubMedCentral Zou X, Zhou X, Ji L, Yang W, Lu J, Weng J, Jia W, Shan Z, Liu J, Tian H, et al. The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study. Sci Rep. 2017;7:46534.CrossRefPubMedPubMedCentral
9.
go back to reference Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed
10.
go back to reference Zheng J, Shen S, Xu H, Zhao Y, Hu Y, Xing Y, Song Y, Wu X. Development and validation of a multivariable risk prediction model for identifying ketosis-prone type 2 diabetes. J Diabetes. 2023. Zheng J, Shen S, Xu H, Zhao Y, Hu Y, Xing Y, Song Y, Wu X. Development and validation of a multivariable risk prediction model for identifying ketosis-prone type 2 diabetes. J Diabetes. 2023.
11.
go back to reference KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 Suppl 2):12–S154. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 Suppl 2):12–S154.
12.
go back to reference Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014;64(4):510–33.CrossRefPubMed Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014;64(4):510–33.CrossRefPubMed
13.
go back to reference Wilkinson CP, Ferris FR, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.CrossRefPubMed Wilkinson CP, Ferris FR, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.CrossRefPubMed
14.
go back to reference Huang JX, Liao YF, Li YM. Clinical features and microvascular complications risk factors of early-onset type 2 diabetes Mellitus. Curr Med Sci. 2019;39(5):754–8.CrossRefPubMed Huang JX, Liao YF, Li YM. Clinical features and microvascular complications risk factors of early-onset type 2 diabetes Mellitus. Curr Med Sci. 2019;39(5):754–8.CrossRefPubMed
15.
go back to reference Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11(5):1245–9.CrossRefPubMed Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11(5):1245–9.CrossRefPubMed
16.
go back to reference Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun WV, Dufour JF, Schattenberg JM, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–9.CrossRefPubMed Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun WV, Dufour JF, Schattenberg JM, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–9.CrossRefPubMed
17.
go back to reference Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, Aravind SR, Sheu W, Nguyen TK, Ozaki R, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2(12):935–43.CrossRefPubMed Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, Aravind SR, Sheu W, Nguyen TK, Ozaki R, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2(12):935–43.CrossRefPubMed
18.
go back to reference Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X, Li L, Ren Y, Qi X, Sun Z, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016;4(2):115–24.CrossRefPubMed Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X, Li L, Ren Y, Qi X, Sun Z, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016;4(2):115–24.CrossRefPubMed
19.
go back to reference Song SH, Hardisty CA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years–clinical observation from a secondary care cohort. QJM. 2009;102(11):799–806.CrossRefPubMed Song SH, Hardisty CA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years–clinical observation from a secondary care cohort. QJM. 2009;102(11):799–806.CrossRefPubMed
20.
go back to reference Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222–32.CrossRefPubMed
21.
go back to reference Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, Shi B, Sun H, Ba J, Chen B, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the american Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.CrossRefPubMedPubMedCentral Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, Shi B, Sun H, Ba J, Chen B, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the american Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.CrossRefPubMedPubMedCentral
22.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.CrossRefPubMed
23.
go back to reference Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes Mellitus. Endocr Rev. 2016;37(3):278–316.CrossRefPubMedPubMedCentral Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes Mellitus. Endocr Rev. 2016;37(3):278–316.CrossRefPubMedPubMedCentral
24.
go back to reference Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal hormone therapy and type 2 diabetes Prevention: evidence, Mechanisms, and clinical implications. Endocr Rev. 2017;38(3):173–88.CrossRefPubMedPubMedCentral Mauvais-Jarvis F, Manson JE, Stevenson JC, Fonseca VA. Menopausal hormone therapy and type 2 diabetes Prevention: evidence, Mechanisms, and clinical implications. Endocr Rev. 2017;38(3):173–88.CrossRefPubMedPubMedCentral
25.
go back to reference Kim KS, Oh HJ, Kim JW, Lee YK, Kim SK, Park SW, Kim YL, Park WK, Cho YW. The clinical characteristics of the newly diagnosed early onset (< 40 years old) diabetes in outpatients’ clinic. Korean Diabetes J. 2010;34(2):119–25.CrossRefPubMedPubMedCentral Kim KS, Oh HJ, Kim JW, Lee YK, Kim SK, Park SW, Kim YL, Park WK, Cho YW. The clinical characteristics of the newly diagnosed early onset (< 40 years old) diabetes in outpatients’ clinic. Korean Diabetes J. 2010;34(2):119–25.CrossRefPubMedPubMedCentral
26.
go back to reference Maccuish AC, Irvine WJ, Barnes EW, Duncan L. Pillars Article: Antibodies to Pancreatic Islet Cells in Insulin-dependent Diabetics with Coexistent Autoimmune Disease. Lancet. 1974. 304: 1529–1531. J Immunol. 2017; 199(9):3019–3021. Maccuish AC, Irvine WJ, Barnes EW, Duncan L. Pillars Article: Antibodies to Pancreatic Islet Cells in Insulin-dependent Diabetics with Coexistent Autoimmune Disease. Lancet. 1974. 304: 1529–1531. J Immunol. 2017; 199(9):3019–3021.
27.
go back to reference Lee BW, Kim SY, Kim JY, Cho KY, Chung YJ, Min YK, Chung JH, Lee MK, Lee MS, Kim KW. Heterogeneity of early-onset and ketosis-resistant diabetes in korean subjects–is it possible to determine cut-off age of early-onset type 2 diabetes? Diabetes Res Clin Pract. 2005;70(1):38–45.CrossRefPubMed Lee BW, Kim SY, Kim JY, Cho KY, Chung YJ, Min YK, Chung JH, Lee MK, Lee MS, Kim KW. Heterogeneity of early-onset and ketosis-resistant diabetes in korean subjects–is it possible to determine cut-off age of early-onset type 2 diabetes? Diabetes Res Clin Pract. 2005;70(1):38–45.CrossRefPubMed
28.
29.
go back to reference Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, Omori Y. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care. 1997;20(5):844–7.CrossRefPubMed Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, Omori Y. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care. 1997;20(5):844–7.CrossRefPubMed
30.
go back to reference Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens. 2008;26(11):2085–92.CrossRefPubMed Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens. 2008;26(11):2085–92.CrossRefPubMed
31.
go back to reference Ren Y, Gao L, Guo X, Huo X, Lu J, Li J, Ji L, Yang X. Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China. J Diabetes Complications. 2018;32(11):1000–5.CrossRefPubMed Ren Y, Gao L, Guo X, Huo X, Lu J, Li J, Ji L, Yang X. Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China. J Diabetes Complications. 2018;32(11):1000–5.CrossRefPubMed
32.
go back to reference Liang CC, Lin PC, Lee MY, Chen SC, Shin SJ, Hsiao PJ, Lin KD, Hsu WH. Association of serum uric acid concentration with Diabetic Retinopathy and Albuminuria in Taiwanese patients with type 2 diabetes Mellitus. Int J Mol Sci 2016; 17(8). Liang CC, Lin PC, Lee MY, Chen SC, Shin SJ, Hsiao PJ, Lin KD, Hsu WH. Association of serum uric acid concentration with Diabetic Retinopathy and Albuminuria in Taiwanese patients with type 2 diabetes Mellitus. Int J Mol Sci 2016; 17(8).
33.
go back to reference Bjornstad P, Laffel L, Lynch J, El GL, Weinstock RS, Tollefsen SE, Nadeau KJ. Elevated serum uric acid is Associated with Greater Risk for Hypertension and Diabetic kidney Diseases in obese adolescents with type 2 diabetes: an observational analysis from the Treatment Options for type 2 diabetes in adolescents and youth (TODAY) study. Diabetes Care. 2019;42(6):1120–8.CrossRefPubMedPubMedCentral Bjornstad P, Laffel L, Lynch J, El GL, Weinstock RS, Tollefsen SE, Nadeau KJ. Elevated serum uric acid is Associated with Greater Risk for Hypertension and Diabetic kidney Diseases in obese adolescents with type 2 diabetes: an observational analysis from the Treatment Options for type 2 diabetes in adolescents and youth (TODAY) study. Diabetes Care. 2019;42(6):1120–8.CrossRefPubMedPubMedCentral
34.
go back to reference Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia. 2008;51(5):714–25.CrossRefPubMedPubMedCentral Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia. 2008;51(5):714–25.CrossRefPubMedPubMedCentral
35.
go back to reference Rodriguez-Poncelas A, Mundet-Tuduri X, Miravet-Jimenez S, Casellas A, Barrot-De LPJ, Franch-Nadal J, Coll-De TG. Chronic kidney Disease and Diabetic Retinopathy in patients with type 2 diabetes. PLoS ONE. 2016;11(2):e149448.CrossRef Rodriguez-Poncelas A, Mundet-Tuduri X, Miravet-Jimenez S, Casellas A, Barrot-De LPJ, Franch-Nadal J, Coll-De TG. Chronic kidney Disease and Diabetic Retinopathy in patients with type 2 diabetes. PLoS ONE. 2016;11(2):e149448.CrossRef
36.
go back to reference Ceriello A, Ihnat MA. Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27(8):862–7.CrossRefPubMed Ceriello A, Ihnat MA. Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27(8):862–7.CrossRefPubMed
37.
go back to reference Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications. J Diabetes Res. 2020; 2020:7489795. Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications. J Diabetes Res. 2020; 2020:7489795.
38.
go back to reference Yan S, Dong W, Li Z, Wei J, Han T, Wang J, Lin F. Metformin regulates chondrocyte senescence and proliferation through microRNA-34a/SIRT1 pathway in osteoarthritis. J Orthop Surg Res. 2023;18(1):198.CrossRefPubMedPubMedCentral Yan S, Dong W, Li Z, Wei J, Han T, Wang J, Lin F. Metformin regulates chondrocyte senescence and proliferation through microRNA-34a/SIRT1 pathway in osteoarthritis. J Orthop Surg Res. 2023;18(1):198.CrossRefPubMedPubMedCentral
39.
go back to reference Concha LL, Durruty AP, Garcia DLRA. [Ketosis prone type 2 diabetes (KPD)]. Rev Med Chil. 2015;143(9):1215–8. Concha LL, Durruty AP, Garcia DLRA. [Ketosis prone type 2 diabetes (KPD)]. Rev Med Chil. 2015;143(9):1215–8.
40.
go back to reference Zhang M, Li Y, Cui W, Yang P, Li H, Sheng C, Cheng X, Qu S, THE CLINICAL AND METABOLIC CHARACTERISTICS OF YOUNG-ONSET KETOSIS-PRONE TYPE 2 DIABETES IN CHINA. Endocr Pract. 2015;21(12):1364–71.CrossRefPubMed Zhang M, Li Y, Cui W, Yang P, Li H, Sheng C, Cheng X, Qu S, THE CLINICAL AND METABOLIC CHARACTERISTICS OF YOUNG-ONSET KETOSIS-PRONE TYPE 2 DIABETES IN CHINA. Endocr Pract. 2015;21(12):1364–71.CrossRefPubMed
41.
go back to reference Alvarez-Aldana D. Improving ketosis-prone type 2 diabetes diagnosis in Africa. Medicc Rev. 2021;23(3–4):61–2.PubMed Alvarez-Aldana D. Improving ketosis-prone type 2 diabetes diagnosis in Africa. Medicc Rev. 2021;23(3–4):61–2.PubMed
42.
go back to reference Xie XJ, Hu Y, Cheng C, Feng TT, He K, Mao XM. Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus? Diabetes Metab Res Rev. 2014;30(1):54–9.CrossRefPubMed Xie XJ, Hu Y, Cheng C, Feng TT, He K, Mao XM. Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus? Diabetes Metab Res Rev. 2014;30(1):54–9.CrossRefPubMed
Metadata
Title
Clinical characteristics of patients with early-onset diabetes mellitus: a single-center retrospective study
Authors
Wenjing Dong
Saichun Zhang
Shiju Yan
Zhizhuang Zhao
Zengqiang Zhang
Weijun Gu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-023-01468-2

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.